PROYECTOS EUROPEOS
Projekt DIRNANO DIRNANO
Directing the immune response through designed nanomaterials
date_range
Dauer von 01 von Oktober von 2020 bis 30 von September von 2024
(48 Monate)
euro
259.904,00 EUR
Geltungsbereich Europäisch.
Forscher/innen
Francisco
Corzana López
Verantwortlich
Publikationen im Zusammenhang mit dem Projekt (6)
Nach Typologie anzeigen2023
-
Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate
VI RSEQ Chemical Biology Group Meeting - ChemBio VI
-
Structure-guided design of unnatural Mucin-1 biomimetics for the development of cancer therapeutic nano-vaccines and diagnostic assays
4th Regular Meeting of the DIRNANO consortium
-
Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models
3rd Regular Meeting of the DIRNANO consortium
-
Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models & biosensor development
5th Regular Meeting of the DIRNANO consortium
2022
-
Directing the immune response through designed nanomaterial. Winter School Presentation
Winter School of the DIRNANO consortium
-
Directing the immune response through designed nanomaterials. Progress Report
1st Regular Meeting of the DIRNANO consortium
Verwandte Forschungsdaten
- PRESENTATION 2nd Regular Meeting of the DIRNANO consortium; ESR14